ImmunityBio, Inc. IBRX
8.64 USD +0.63 (+7.80%)
At closeNov 6, 2026, 7:59 PM EST
8.59 -0.04 -0.48%
After hours · Nov 6, 7:59 PM ET
7.88 Day range 8.69
1.95 52-week range 12.43
- YTD
- +336.11%
- 1 year
- +307.31%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 113.29M | 14.74M | 622.00K | 240.00K | 934.00K | |
| 112.53M | 14.74M | 622.00K | 240.00K | 934.00K | |
| -256.03M | -344.18M | -362.25M | -351.30M | -330.28M | |
| -351.40M | -413.56M | -583.20M | -416.57M | -346.79M | |
| -0.38 | -0.62 | -1.15 | -1.04 | -0.89 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 88.33M | 143.43M | 265.45M | 104.64M | 181.10M | |
| 501.90M | 382.93M | 504.45M | 362.36M | 468.91M | |
| 1.00B | 871.06M | 1.09B | 812.18M | 712.82M | |
| 842.69M | 788.57M | 882.14M | 723.77M | 645.66M | |
| -500.47M | -489.10M | -586.99M | -447.33M | -242.17M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -304.94M | -391.24M | -366.76M | -337.51M | -274.42M | |
| -149.80M | -12.25M | -30.47M | 27.30M | -84.89M | |
| 400.24M | 281.63M | 558.34M | 233.61M | 505.44M | |
| -4.25M | -6.89M | -30.58M | -78.16M | -13.06M | |
| -54.48M | -121.88M | 160.82M | -76.31M | 146.19M |